BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

844 related articles for article (PubMed ID: 19292017)

  • 1. [Mechanisms of myocardial cell protection from ischemia/reperfusion injury and potential clinical implications].
    Lamendola P; Di Monaco A; Barone L; Pisanello C; Lanza GA; Crea F
    G Ital Cardiol (Rome); 2009 Jan; 10(1):28-36. PubMed ID: 19292017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reperfusion and postconditioning in acute ST segment elevation myocardial infarction. A new paradigm for the treatment of acute myocardial infarction. From bench to bedside?].
    Lupi Herrera E; Gaspar J; González Pacheco H; Martínez Sánchez C; Pastelín Hernández G; Luna Ortiz P; Chávez Cosio E
    Arch Cardiol Mex; 2006; 76 Suppl 4():S76-101. PubMed ID: 17469337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Trimetazidine and cardioprotection during ischemia-reperfusion].
    Barsotti A; Di Napoli P
    Ital Heart J; 2004 Mar; 5 Suppl 2():29S-36S. PubMed ID: 15074775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic disarrangement in ischemic heart disease and its therapeutic control.
    Ferrari R
    Rev Port Cardiol; 1998 Sep; 17(9):667-84. PubMed ID: 9834638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial ischemia and reperfusion injury.
    Buja LM
    Cardiovasc Pathol; 2005; 14(4):170-5. PubMed ID: 16009313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ischaemic heart disease: clinical improvement with metabolic approach.
    Ferrari R
    Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V7-20. PubMed ID: 11206104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postconditioning: reduction of reperfusion-induced injury.
    Zhao ZQ; Vinten-Johansen J
    Cardiovasc Res; 2006 May; 70(2):200-11. PubMed ID: 16545349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ischemic preconditioning protects cardiomyocytes against ischemic injury by inducing GRP78.
    Shintani-Ishida K; Nakajima M; Uemura K; Yoshida K
    Biochem Biophys Res Commun; 2006 Jul; 345(4):1600-5. PubMed ID: 16735028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Postconditioning: a brief review].
    Schipke JD; Kerendi F; Gams E; Vinten-Johansen J
    Herz; 2006 Sep; 31(6):600-6. PubMed ID: 17036192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic efficiency with ranolazine for less ischemia in non-ST elevation acute coronary syndromes (MERLIN TIMI-36) study.
    Melloni C; Newby LK
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):9-16. PubMed ID: 18095903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New pharmacologic options in the treatment of acute coronary syndromes and myocardial ischemia-reperfusion injury: potential role of levosimendan.
    Garcia-Gonzalez MJ; Dominguez-Rodriguez A; Abreu-Gonzalez P
    Minerva Cardioangiol; 2007 Oct; 55(5):625-35. PubMed ID: 17912166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ischemic preconditioning and arterial collateral flow on ST-segment elevation and QRS complex prolongation in a canine model of acute coronary occlusion.
    Floyd JS; Maynard C; Weston P; Johanson P; Jennings RB; Wagner GS
    J Electrocardiol; 2009; 42(1):19-26. PubMed ID: 19070706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commentary on selected aspects of cardioprotection.
    Jennings RB
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):340-8. PubMed ID: 21821537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiology and pharmacology of myocardial preconditioning.
    Raphael J
    Semin Cardiothorac Vasc Anesth; 2010 Mar; 14(1):54-9. PubMed ID: 20472628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology of myocardial infarction: protection by ischemic pre- and postconditioning.
    Skyschally A; Schulz R; Heusch G
    Herz; 2008 Mar; 33(2):88-100. PubMed ID: 18344027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reperfusion injury in humans: a review of clinical trials on reperfusion injury inhibitory strategies.
    Dirksen MT; Laarman GJ; Simoons ML; Duncker DJ
    Cardiovasc Res; 2007 Jun; 74(3):343-55. PubMed ID: 17306241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial protection in reperfusion with postconditioning.
    Vinten-Johansen J; Zhao ZQ; Jiang R; Zatta AJ
    Expert Rev Cardiovasc Ther; 2005 Nov; 3(6):1035-45. PubMed ID: 16292995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial protection by anesthetic agents against ischemia-reperfusion injury: an update for anesthesiologists.
    Kato R; Foëx P
    Can J Anaesth; 2002 Oct; 49(8):777-91. PubMed ID: 12374705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre- and postconditioning during cardiac surgery.
    Valen G; Vaage J
    Basic Res Cardiol; 2005 May; 100(3):179-86. PubMed ID: 15723155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.